VJHemOnc is committed to improving our service to you

EHA 2020 | EHA 2020: what to keep an eye out for in MPNs

VJHemOnc is committed to improving our service to you

Srdan Verstovsek

Srdan Verstovsek, MD, PhD, of the University of Texas MD Anderson Cancer Center, Houston, TX, discusses key developments in the treatment of myeloproliferative neoplasms (MPNs) presented at the 25th Annual European Hematology Association (EHA) conference. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter